Type to search…

Dual GLP-1/GIP receptor agonist for glycaemic control and metabolic research. Supplied as lyophilized powder in 10 mg vials.
Tirzepatide is a dual GLP-1/GIP receptor agonist used in glycaemic control and metabolic research. It is supplied as lyophilized powder in 10 mg vials and is notable as the first research compound designed to target both incretin pathways simultaneously.